Teleflex Investors to Put a Lost Decade Behind

Teleflex (TFX), a medical device manufacturer, has underperformed significantly with stock down 70% from 2021 highs. However, new leadership and a restructuring plan involving $800M debt paydown and $1B stock buybacks, combined with a 2027 P/E of 12.5, present potential recovery opportunities. Technical analysis suggests a bullish Elliott Wave setup with potential for the stock to double to $260 resistance levels.

05/19/2026, 1:05 PM • Investing

Teleflex Stock Surges Over 8% In Pre-Market Trading: Here's Why

Teleflex (NYSE:TFX) shares jumped 8.22% in pre-market trading after private equity firms CVC Capital Partners and GTCR submitted a joint bid to take the medical device maker private. The bid follows activist pressure from Irenic Capital Management in March. However, the offer is under evaluation with no certainty of deal completion. Teleflex had missed earnings expectations significantly in Q4, with EPS at $1.93 versus $3.74 estimate.

04/22/2026, 5:33 AM • Benzinga

Teleflex Incorporated Investigated by the Portnoy Law Firm

The Portnoy Law Firm has initiated a securities fraud investigation into Teleflex Incorporated following a 13.06% stock price decline on January 8, 2026. The sharp drop was triggered by the sudden departure of CEO Liam Kelly from his roles as Chairman, President, and Chief Executive Officer, creating investor concerns about leadership continuity and strategic direction.

04/17/2026, 9:00 AM • GlobeNewswire

Activist Investor Urges Teleflex To Engage Potential Buyers

Irenic Capital, holding a 2% stake in Teleflex, has pressured the board to engage with potential acquirers to maximize shareholder value. The activist investor highlights a 73% shareholder return decline over five years and criticizes the board's long tenure and lack of open market stock purchases. Teleflex shares rose 5.37% on the news, though technical indicators show mixed momentum with bearish MACD signals and a neutral RSI.

03/27/2026, 1:20 PM • Benzinga

Nasdaq 100 Enters Correction As 30-Year Yields Near 5%: What's Moving Markets Friday?

U.S. equities tumbled to their lowest levels in nearly seven months on Friday as the Nasdaq 100 officially entered correction territory, down over 10% from January highs. The decline was driven by geopolitical tensions with Iran rejecting ceasefire options, surging crude oil prices, deteriorating consumer sentiment, and rising inflation expectations. The 30-year Treasury yield climbed to 4.958%, threatening to breach 5% for the first time since July 2025, while the Fed rate hike probability by December jumped to nearly 50%.

03/27/2026, 1:09 PM • Benzinga

Pulmonary Artery Catheter Market Size to Reach USD 1.97 Billion by 2035 Caused by the Surging Critical Care Procedures Globally

The global Pulmonary Artery Catheter Market is valued at USD 1.23 billion in 2025 and is projected to reach USD 1.97 billion by 2035, growing at a CAGR of 4.87%. Growth is driven by increasing critical care procedures, rising cardiovascular disease prevalence, expanding ICU capacities, and demand for precise hemodynamic monitoring. The U.S. market is expected to grow from USD 0.38 billion to USD 0.58 billion during the same period.

02/17/2026, 4:00 AM • GlobeNewswire

Synthetic Absorbable Sutures Market Size to Hit USD 4.36 Billion by 2033, Driven by Rising Surgical Volumes and Minimally Invasive Procedures – SNS Insider

The global synthetic absorbable sutures market is valued at USD 2.51 billion in 2025 and is projected to reach USD 4.36 billion by 2033, growing at a CAGR of 7.19%. Growth is driven by rising surgical volumes, increasing adoption of minimally invasive procedures, and advancements in polymer technology. However, higher costs compared to conventional sutures may limit adoption in cost-sensitive markets. North America leads with 40% market share, while Asia Pacific is expected to grow fastest at 9.31% CAGR.

01/19/2026, 9:00 AM • GlobeNewswire

Global Catheters Market Size to Hit USD 55.58 Billion by 2033, Driven by Rising Cardiovascular and Urological Procedures – SNS Insider

The global catheters market is projected to grow from USD 29.17 billion in 2025 to USD 55.58 billion by 2033, with a CAGR of 8.41%. Growth is driven by increasing cardiovascular and urological procedures, aging populations, and technological advancements. However, catheter-associated infections and antibiotic resistance pose challenges. North America dominates with 38.05% market share, while Asia Pacific is the fastest-growing region at 9.23% CAGR.

01/12/2026, 7:52 AM • GlobeNewswire

Pulmonary Function Testing Market Size to Hit USD 5.66 Billion by 2033, Growing at a CAGR of 6.65% - SNS Insider

The global pulmonary function testing market is projected to grow from USD 3.39 billion in 2025 to USD 5.66 billion by 2033, with a CAGR of 6.65%. Growth is driven by rising prevalence of chronic respiratory diseases, an aging population, and technological advancements in diagnostic devices. The U.S. market is expected to expand from USD 1.03 billion to USD 1.67 billion during the same period. Asia Pacific is anticipated to experience the fastest regional growth at 7.27% CAGR.

01/09/2026, 7:00 AM • GlobeNewswire

Global Disposable Endoscopes Market to Accelerate at a CAGR of ~10% by 2032 as Healthcare Shifts Toward Infection-Free Diagnostic Solutions | DelveInsight

The global disposable endoscopes market is expected to grow from USD 2.6 billion in 2024 to USD 5.7 billion by 2032, driven by healthcare providers' focus on infection control, minimally invasive procedures, and technological advancements. North America leads the market, while Asia-Pacific is expected to experience the fastest growth. Key players include Olympus, Boston Scientific, and Ambu, with recent developments including product launches and manufacturing expansions.

01/08/2026, 1:00 PM • GlobeNewswire

Coloplast annoncerer ændringer i ledelsesteamet

Coloplast announces leadership transitions, with Dorthe Rønnau leaving People & Culture and Tommy Johns retiring from Urologi. Kevin Hardage will join as new Urologi leader, bringing extensive medtech experience.

12/18/2025, 9:00 AM • GlobeNewswire

U.S. Arteriovenous Fistula Devices Market Trends Analysis Report 2025-2033: Lucrative Opportunities Stem from Rising ESRD Cases, Driving Demand for AVF Solutions

The U.S. arteriovenous fistula devices market is projected to grow from $112 million in 2025 to $120 million by 2033, driven by rising end-stage renal disease cases and increasing demand for advanced vascular access solutions.

11/19/2025, 4:57 AM • GlobeNewswire

Intravenous Catheters Market Size to Hit USD 16.47 Billion by 2032, at 6.9% CAGR | Report by SNS Insider

The global intravenous catheters market is projected to grow from USD 9.06 billion in 2024 to USD 16.47 billion by 2032, driven by rising chronic disease prevalence and increasing demand for outpatient and home-based IV therapies.

08/19/2025, 9:00 AM • GlobeNewswire

Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business

Teleflex has completed its acquisition of BIOTRONIK's Vascular Intervention business for €760 million, expanding its global presence in the cath lab and peripheral intervention market with a comprehensive portfolio of medical technologies.

07/01/2025, 6:30 AM • Benzinga